Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

P Lim

Showing results (831-840 of 847) with videos related to

Pageof 85
Sort By:
Plos Medicine|July 30, 2020
Obesity, clinical, and genetic predictors for glycemic progression in Chinese patients with type 2 diabetes: A cohort study using the Hong Kong Diabetes Register and Hong Kong Diabetes BiobankGuozhi Jiang, Andrea O Luk, Claudia H T Tam, et al.
Diabetes|January 19, 2022
Clinical Predictors and Long-term Impact of Acute Kidney Injury on Progression of Diabetic Kidney Disease in Chinese Patients With Type 2 DiabetesGuozhi Jiang, Andrea O Luk, Claudia H T Tam, et al.
Journal of the National Cancer Institute|November 30, 2018
A Prospective Study of Circulating Tumor DNA to Guide Matched Targeted Therapy in Lung CancersJoshua K Sabari, Michael Offin, Dennis Stephens, et al.
The New England Journal of Medicine|June 23, 2021
Acquired Resistance to KRAS<sup>G12C</sup> Inhibition in CancerMark M Awad, Shengwu Liu, Igor I Rybkin, et al.
American Journal of Kidney Diseases : the Official Journal of the National Kidney Foundation|January 9, 2022
Nonalbuminuric Diabetic Kidney Disease and Risk of All-Cause Mortality and Cardiovascular and Kidney Outcomes in Type 2 Diabetes: Findings From the Hong Kong Diabetes BiobankQiao Jin, Andrea O Luk, Eric S H Lau, et al.
Cardiovascular Diabetology|December 31, 2022
High-density lipoprotein subclasses and cardiovascular disease and mortality in type 2 diabetes: analysis from the Hong Kong Diabetes BiobankQiao Jin, Eric S H Lau, Andrea O Luk, et al.
Diabetologia|November 12, 2024
Type 2 diabetes pathway-specific polygenic risk scores elucidate heterogeneity in clinical presentation, disease progression and diabetic complications in 18,217 Chinese individuals with type 2 diabetesGechang Yu, Claudia H T Tam, Cadmon K P Lim, et al.
Cell|May 15, 2018
Interfaces of Malignant and Immunologic Clonal Dynamics in Ovarian CancerAllen W Zhang, Andrew McPherson, Katy Milne, et al.
Genome Medicine|February 20, 2021
Development of genome-wide polygenic risk scores for lipid traits and clinical applications for dyslipidemia, subclinical atherosclerosis, and diabetes cardiovascular complications among East AsiansClaudia H T Tam, Cadmon K P Lim, Andrea O Y Luk, et al.
Biorxiv : the Preprint Server for Biology|July 29, 2024
Ongoing genome doubling promotes evolvability and immune dysregulation in ovarian cancerAndrew McPherson, Ignacio Vázquez-García, Matthew A Myers, et al.
Pageof 85

Showing results (831-840 of 847) with videos related to

Sort By:
Pageof 85
Plos Medicine|July 30, 2020
Obesity, clinical, and genetic predictors for glycemic progression in Chinese patients with type 2 diabetes: A cohort study using the Hong Kong Diabetes Register and Hong Kong Diabetes BiobankGuozhi Jiang, Andrea O Luk, Claudia H T Tam, et al.
Diabetes|January 19, 2022
Clinical Predictors and Long-term Impact of Acute Kidney Injury on Progression of Diabetic Kidney Disease in Chinese Patients With Type 2 DiabetesGuozhi Jiang, Andrea O Luk, Claudia H T Tam, et al.
Journal of the National Cancer Institute|November 30, 2018
A Prospective Study of Circulating Tumor DNA to Guide Matched Targeted Therapy in Lung CancersJoshua K Sabari, Michael Offin, Dennis Stephens, et al.
The New England Journal of Medicine|June 23, 2021
Acquired Resistance to KRAS<sup>G12C</sup> Inhibition in CancerMark M Awad, Shengwu Liu, Igor I Rybkin, et al.
American Journal of Kidney Diseases : the Official Journal of the National Kidney Foundation|January 9, 2022
Nonalbuminuric Diabetic Kidney Disease and Risk of All-Cause Mortality and Cardiovascular and Kidney Outcomes in Type 2 Diabetes: Findings From the Hong Kong Diabetes BiobankQiao Jin, Andrea O Luk, Eric S H Lau, et al.
Cardiovascular Diabetology|December 31, 2022
High-density lipoprotein subclasses and cardiovascular disease and mortality in type 2 diabetes: analysis from the Hong Kong Diabetes BiobankQiao Jin, Eric S H Lau, Andrea O Luk, et al.
Diabetologia|November 12, 2024
Type 2 diabetes pathway-specific polygenic risk scores elucidate heterogeneity in clinical presentation, disease progression and diabetic complications in 18,217 Chinese individuals with type 2 diabetesGechang Yu, Claudia H T Tam, Cadmon K P Lim, et al.
Cell|May 15, 2018
Interfaces of Malignant and Immunologic Clonal Dynamics in Ovarian CancerAllen W Zhang, Andrew McPherson, Katy Milne, et al.
Genome Medicine|February 20, 2021
Development of genome-wide polygenic risk scores for lipid traits and clinical applications for dyslipidemia, subclinical atherosclerosis, and diabetes cardiovascular complications among East AsiansClaudia H T Tam, Cadmon K P Lim, Andrea O Y Luk, et al.
Biorxiv : the Preprint Server for Biology|July 29, 2024
Ongoing genome doubling promotes evolvability and immune dysregulation in ovarian cancerAndrew McPherson, Ignacio Vázquez-García, Matthew A Myers, et al.
Pageof 85